These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25804123)

  • 1. PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.
    Dimitrakopoulou-Strauss A
    Future Oncol; 2015; 11(7):1083-91. PubMed ID: 25804123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.
    Basu S; Alavi A
    PET Clin; 2016 Jul; 11(3):203-7. PubMed ID: 27321025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
    Sheikhbahaei S; Mena E; Pattanayak P; Taghipour M; Solnes LB; Subramaniam RM
    PET Clin; 2017 Jan; 12(1):105-118. PubMed ID: 27863562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Basu B; Basu S
    Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CT.
    Basu S
    Discov Med; 2012 Jan; 13(68):65-73. PubMed ID: 22284785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1165-1182. PubMed ID: 29907486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
    Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
    Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From pure research imaging tool to PET-guided personalized medicine in oncology: a true revolution in modern medicine.
    Basu S
    Indian J Cancer; 2010; 47(2):98-9. PubMed ID: 20448370
    [No Abstract]   [Full Text] [Related]  

  • 9. The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
    Pruis IJ; van Dongen GAMS; Veldhuijzen van Zanten SEM
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging requirements for personalized medicine: the oncologists point of view.
    Kruse V; Belle SV; Cocquyt V
    Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
    Subramaniam RM
    PET Clin; 2017 Jan; 12(1):1-5. PubMed ID: 27863561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Advances in Imaging Will Affect Precision Radiation Oncology.
    Jaffray DA; Das S; Jacobs PM; Jeraj R; Lambin P
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):292-298. PubMed ID: 29726358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
    Sunderland JJ; Christian PE
    J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.
    Ceci F; Castellucci P; Graziani T; Schiavina R; Fanti S
    PET Clin; 2015 Oct; 10(4):487-94. PubMed ID: 26384595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron Emission Tomography in oncology: present and future of PET and PET/CT.
    Papathanassiou D; Bruna-Muraille C; Liehn JC; Nguyen TD; Curé H
    Crit Rev Oncol Hematol; 2009 Dec; 72(3):239-54. PubMed ID: 19091592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging in the framework of personalized cancer medicine.
    Belkić D; Belkić K
    Isr Med Assoc J; 2013 Nov; 15(11):665-72. PubMed ID: 24511645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular image-guided theranostic and personalized medicine 2014.
    Zhang H; Tian M; Carrio I; Civelek AC; Fujibayashi Y
    Biomed Res Int; 2015; 2015():258612. PubMed ID: 25883947
    [No Abstract]   [Full Text] [Related]  

  • 19. New PET imaging agents in the management of solid cancers.
    Garcia C; Gebhart G; Flamen P
    Curr Opin Oncol; 2012 Nov; 24(6):748-55. PubMed ID: 22913970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.
    Gabriel M; Andergassen U; Putzer D; Kroiss A; Waitz D; Von Guggenberg E; Kendler D; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):92-9. PubMed ID: 20168291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.